India highlights development of Covid-19 vaccines in Cuba
New Delhi, Feb 26 (Prensa Latina) Cuba is the only country in Latin America and the Caribbean that develops its own Covid-19 vaccines, the Indian media reports.
The country has four candidate vaccines and two of them, Soberana 02 and Abdala, from the Finlay Vaccine Institute and the Center for Genetic Engineering and Biotechnology, respectively, will enter the third phase of clinical trials in March, the News Click and Peoples Distpach portals reported.
Soberana 01, Soberana 02 and Abdala are injectable vaccines, administered traditionally, while Mambisa is a non-injectable vaccine administered through the nose.
Soberana 02 and Abdala show elevated immune responses against coronavirus. They also cause few side effects, such as mild pain around the injection site.
Unlike Pfizer and Moderna vaccines, they do not require deep freezing, and are cheaper and more viable options for poor countries that lack freezing equipment.
Soberana 02 requires the administration of three doses at two-week intervals, while Abdala requires two doses three weeks apart. Iran, Venezuela, Vietnam, India and Pakistan have showed interest in acquiring them.
Cuba expects to produce 100 million doses of Soberana 02 this year to vaccinate its entire population of 11 million people and export to other countries by the end of the year. In addition, it announced its donation to poor countries.
|By the minute||Most read|